ARKG Holdings of VCYT
Veracyte
Veracyte, Inc. operates in the field of genomic diagnostics, providing advanced diagnostic testing solutions to improve clinical outcomes for patients, primarily in the areas of oncology and pulmonology. The company generates revenue by offering its proprietary genomic tests to healthcare providers, which assist in more accurate diagnosis and treatment decisions, as well as by licensing its technology and intellectual property.
Trades of VCYT in ARKG
The ten most recent trades of Veracyte in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Jan 13, 2025 | Sell | $1,580,991 | 2.92% | 0.14% |
| Jan 08, 2025 | Sell | $1,002,874 | 1.80% | 0.09% |
| Dec 30, 2024 | Sell | $225,991 | 0.44% | 0.02% |
| Dec 24, 2024 | Sell | $187,657 | 0.35% | 0.02% |
| Dec 20, 2024 | Sell | $1,713,256 | 3.17% | 0.17% |
| Dec 11, 2024 | Sell | $1,361,051 | 2.25% | 0.11% |
| Nov 11, 2024 | Sell | $2,046,821 | 3.75% | 0.16% |
| Oct 28, 2024 | Sell | $2,473,677 | 4.85% | 0.21% |
| Aug 12, 2024 | Sell | $912,891 | 2.02% | 0.07% |
| Aug 09, 2024 | Sell | $1,656,609 | 3.49% | 0.13% |